GlassScriptPhysician profile
Rajeev Chaturvedi
NPI 1376686303
$5,633.07
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $832 · 2021: $1,094 · 2022: $3,000 · 2023: $17.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainsway USA INC | $3,017.72 | 2022-2023 | |
| Alkermes, INC. | $1,012.37 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $369.79 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $287.97 | 2020-2021 | |
| Abbvie INC. | $134.37 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $132.92 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.19 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $93.89 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $91.39 | 2020-2021 | |
| Allergan, INC. | $87.58 | 2020 | |
| Lundbeck LLC | $60.40 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $59.30 | 2021 | |
| Eisai INC. | $58.19 | 2020-2021 | |
| Neos Therapeutics, LP | $46.84 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $42.66 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $25.49 | 2020-2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Chaturvedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.